Healthium Medtech, a global medical technology company with a strong and expanding presence across surgical, post-surgical, advanced wound care, arthroscopy, and infection prevention, has announced that it has agreed to acquire a controlling stake in Paramount Surgimed Ltd. Paramount is one of India’s largest manufacturers and exporters of surgical blades, scalpels, and dermal biopsy products.
Prior to the transaction, Paramount’s non-surgical businesses, including its lifestyle and hygiene portfolio, will be carved out and retained by the Grover family.
Strengthening Surgical Consumables Portfolio
With this acquisition, Healthium will significantly strengthen its specialised presence in the surgical consumables segment. Paramount’s leadership in blades and dermal biopsy products represents a natural extension of Healthium’s existing offerings.
As a result, the alignment creates strong two-way synergies. Healthium will broaden its range of surgical solutions, while both organisations will gain the ability to serve customers with a more comprehensive and integrated product portfolio. Moreover, Paramount’s scaled manufacturing capabilities and high-quality products add a compelling value proposition for customers worldwide.
Unlocking Global Growth and Innovation
When combined with Healthium’s scale, distribution network, and global market reach, the acquisition is expected to unlock opportunities for accelerated commercial expansion, shared research and development, and the creation of differentiated, high-quality innovations. Together, the two companies aim to strengthen their competitive position across global markets.
Paramount’s Strong Global Manufacturing Footprint
Paramount Surgimed brings more than three decades of specialised manufacturing expertise and a strong export-driven business model. Exports contribute to over 95 percent of its revenue, reflecting its deep international presence.
Currently, the company serves more than 300 OEM and branded customers across over 100 countries. This reach is supported by comprehensive international regulatory approvals, including EU MDR and US FDA registrations. In addition, Paramount manufactures more than 250 million devices annually, positioning it among the largest players in the surgical blades and biopsy products segment.
Healthium Leadership Highlights Strategic Fit
Commenting on the acquisition, Anish Bafna, CEO and Managing Director of Healthium Medtech, said the move strengthens Healthium’s global surgical consumables business and aligns with its strategy of delivering high-precision technologies to healthcare professionals worldwide.
He noted that Paramount has earned strong clinician trust through consistent performance, rigorous execution, and manufacturing excellence. He further emphasised that Healthium will prioritise a smooth integration process that preserves the qualities customers value, while enhancing service levels and supply reliability. According to him, the partnership presents an opportunity to align strengths and build a more competitive global platform in surgical consumables.
Paramount Leadership Welcomes Strategic Partnership
As per the press release, Shaily Grover, Managing Director of Paramount Surgimed Ltd., expressed confidence in the partnership and its growth potential. She stated that partnering with Healthium for the surgical disposables business marks an important next phase for Paramount. She highlighted Healthium’s operational expertise and global reach as key strengths that make it an ideal partner.
Shaily Grover added that Paramount has always stood for precision, quality, and trust, and expects the brand to grow significantly under Healthium’s platform. By leveraging broader resources and an expanded portfolio, the partnership aims to improve reliability and expand market access globally.
Vision for Scale and Global Impact
Looking ahead, Daksh Grover, Director of Paramount Surgimed Ltd., described the partnership as highly synergistic. As Paramount enters this new phase, he remains committed to leading the business and delivering sustained high growth while ensuring continuity for customers.
He concluded that the partnership sets the stage for unprecedented scale and impact. With their combined product portfolios and global capabilities, the two organisations can redefine the global surgical consumables landscape and operate at unprecedented speed and scale.